Processa Pharmaceuticals, Inc. Share Price
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
01:30:00 12/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.080 USD | +12.43% |
|
+1.46% | -27.78% |
| Market Cap | 58.1L 50.06L 47.4L 42.96L 80.6L 56Cr 81.01L 5.63Cr 2.16Cr 28Cr 2.18Cr 2.13Cr 89Cr | P/E 2024 |
-0.23x | P/E 2025 | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | 3L 2L 2L 2L 4L 2.61Cr 4L 26.48L 10.18L 1.33Cr 10.26L 10.04L 4.2Cr | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
85.18% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PCSA | Delayed | |
CBOE
| PCSA | Real-time |
Last Transcript : Processa Pharmaceuticals, Inc.
| 1 day | +12.43% | ||
| 1 week | +1.46% | ||
| Current month | +1.46% | ||
| 1 month | -20.31% | ||
| 3 months | +5.05% | ||
| 6 months | -28.77% | ||
| Current year | -27.78% |
| 1 week | 1.82 |  | 2.16 |
| 1 month | 1.82 | | 2.68 |
| Current year | 1.67 | | 3.8 |
| 1 year | 1.67 | | 14.24 |
| 3 years | 1.67 | | 450 |
| 5 years | 1.67 | | 4,495.35 |
| 10 years | 1.67 | | 1,25,195.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Ng
CEO | Chief Executive Officer | 52 | 08/08/2023 |
Patrick Lin
IRC | Investor Relations Contact | 60 | 29/03/2011 |
Wendy Guy
ADM | Chief Administrative Officer | 61 | 04/10/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
David Young
CHM | Chairman | 73 | 29/03/2011 |
Justin Yorke
CHM | Chairman | 60 | 16/08/2022 |
Geraldine Pannu
BRD | Director/Board Member | 56 | 13/02/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/08/26 | Exercice | Chief Executive Officer | 3,200 | 0.1156% | ||
| 26/07/26 | Other | Chief Financial Officer | 11,883 | 0.4293% | ||
| 26/07/26 | Other | Chief Executive Officer | 9,384 | 0.3390% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +12.43% | +1.46% | -56.58% | -98.51% | 51.68L | |
| -2.11% | -3.44% | +41.04% | +98.48% | 6.82TCr | |
| -0.23% | -6.42% | +30.19% | +76.15% | 6.22TCr | |
| +1.67% | +2.16% | -11.32% | +392.80% | 2.78TCr | |
| -1.05% | -7.30% | +25.00% | +12.31% | 2.49TCr | |
| +0.34% | -5.98% | -4.23% | -19.48% | 2.42TCr | |
| +0.43% | -4.78% | +18.26% | -20.61% | 1.94TCr | |
| -3.03% | -5.19% | +192.88% | +340.13% | 1.73TCr | |
| -1.94% | -6.36% | -7.05% | +516.16% | 1.45TCr | |
| -2.28% | -5.09% | +48.86% | +153.82% | 1.42TCr | |
| Average | +0.42% | -4.54% | +27.71% | +145.13% | 2.73TCr | |
| Weighted average by Cap. | -0.86% | -3.80% | +33.61% | +136.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.19Cr -1.02Cr -96.68L -87.63L -1.64Cr -113.21Cr -1.65Cr -11Cr -4.42Cr -58Cr -4.45Cr -4.35Cr -182Cr | -1.36Cr -1.17Cr -1.11Cr -1Cr -1.88Cr -129.58Cr -1.89Cr -13Cr -5.05Cr -66Cr -5.09Cr -4.98Cr -208.32Cr |
| Net Debt | -11.18L -10L -9L -8L -15.51L -11Cr -15.59L -1.08Cr -41.65L -5.43Cr -41.98L -41.06L -17Cr | -55.37L -47.71L -45.17L -40.94L -76.81L -53Cr -77.2L -5.36Cr -2.06Cr -27Cr -2.08Cr -2.03Cr -85Cr |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | $2.080 | +12.43% | 38,989 |
| 10/26/10 | $1.850 | -7.04% | 1,02,278 |
| 09/26/09 | $1.990 | -7.87% | 25,465 |
| 08/26/08 | $2.160 | +4.85% | 35,841 |
| 04/26/04 | $2.060 | +0.49% | 12,344 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PCSA Stock
Select your edition
All financial news and data tailored to specific country editions
